Results
|
|
41.
|
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer. [electronic resource] by
- Dawson, N A
- Figg, W D
- Cooper, M R
- Sartor, O
- Bergan, R C
- Senderowicz, A M
- Steinberg, S M
- Tompkins, A
- Weinberger, B
- Sausville, E A
- Reed, E
- Myers, C E
Producer: 19970710
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 15
Availability: No items available.
|
|
|
42.
|
Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin. [electronic resource] by
- Senderowicz, A M
- Vitetta, E
- Headlee, D
- Ghetie, V
- Uhr, J W
- Figg, W D
- Lush, R M
- Stetler-Stevenson, M
- Kershaw, G
- Kingma, D W
- Jaffe, E S
- Sausville, E A
Producer: 19970529
In:
Annals of internal medicine vol. 126
Availability: No items available.
|
|
|
43.
|
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. [electronic resource] by
- Dawson, N
- Figg, W D
- Brawley, O W
- Bergan, R
- Cooper, M R
- Senderowicz, A
- Headlee, D
- Steinberg, S M
- Sutherland, M
- Patronas, N
- Sausville, E
- Linehan, W M
- Reed, E
- Sartor, O
Producer: 19980409
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 4
Availability: No items available.
|
|
|
44.
|
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. [electronic resource] by
- Sausville, E A
- Arbuck, S G
- Messmann, R
- Headlee, D
- Bauer, K S
- Lush, R M
- Murgo, A
- Figg, W D
- Lahusen, T
- Jaken, S
- Jing , X
- Roberge, M
- Fuse, E
- Kuwabara, T
- Senderowicz, A M
Producer: 20010517
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
|
45.
|
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. [electronic resource] by
- Leost, M
- Schultz, C
- Link, A
- Wu, Y Z
- Biernat, J
- Mandelkow, E M
- Bibb, J A
- Snyder, G L
- Greengard, P
- Zaharevitz, D W
- Gussio, R
- Senderowicz, A M
- Sausville, E A
- Kunick, C
- Meijer, L
Producer: 20001113
In:
European journal of biochemistry vol. 267
Availability: No items available.
|
|
|
46.
|
Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein. [electronic resource] by
- Fuse, E
- Tanii, H
- Kurata, N
- Kobayashi, H
- Shimada, Y
- Tamura, T
- Sasaki, Y
- Tanigawara, Y
- Lush, R D
- Headlee, D
- Figg, W D
- Arbuck, S G
- Senderowicz, A M
- Sausville, E A
- Akinaga, S
- Kuwabara, T
- Kobayashi, S
Producer: 19980827
In:
Cancer research vol. 58
Availability: No items available.
|
|
|
47.
|
A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. [electronic resource] by
- Messmann, R A
- Vitetta, E S
- Headlee, D
- Senderowicz, A M
- Figg, W D
- Schindler, J
- Michiel, D F
- Creekmore, S
- Steinberg, S M
- Kohler, D
- Jaffe, E S
- Stetler-Stevenson, M
- Chen, H
- Ghetie, V
- Sausville, E A
Producer: 20000803
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
|
48.
|
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. [electronic resource] by
- Stone, M J
- Sausville, E A
- Fay, J W
- Headlee, D
- Collins, R H
- Figg, W D
- Stetler-Stevenson, M
- Jain, V
- Jaffe, E S
- Solomon, D
- Lush, R M
- Senderowicz, A
- Ghetie, V
- Schindler, J
- Uhr, J W
- Vitetta, E S
Producer: 19960905
In:
Blood vol. 88
Availability: No items available.
|
|
|
49.
|
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma. [electronic resource] by
- Voss, M H
- Hussain, A
- Vogelzang, N
- Lee, J L
- Keam, B
- Rha, S Y
- Vaishampayan, U
- Harris, W B
- Richey, S
- Randall, J M
- Shaffer, D
- Cohn, A
- Crowell, T
- Li, J
- Senderowicz, A
- Stone, E
- Figlin, R
- Motzer, R J
- Haas, N B
- Hutson, T
Producer: 20180302
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
50.
|
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial. [electronic resource] by
- Keefe, S M
- Hoffman-Censits, J
- Cohen, R B
- Mamtani, R
- Heitjan, D
- Eliasof, S
- Nixon, A
- Turnbull, B
- Garmey, E G
- Gunnarsson, O
- Waliki, M
- Ciconte, J
- Jayaraman, L
- Senderowicz, A
- Tellez, A B
- Hennessy, M
- Piscitelli, A
- Vaughn, D
- Smith, A
- Haas, N B
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|